Retreatment of IFN/ribavirin non-responder hepatitis C patients: Benefit of PEG-interferon/ribavirin amantadine.

被引：0
|
作者：
Maynard, M
Ahmed, SNS
Bailly, F
Rozier, F
Benmakhlouf, N
Bourne-Branchu, V
Fazly, T
Nemoz, C
Adeleine, P
Pradat, P
Trepo, C
机构：
[1] Hop Hotel Dieu, Lyon, France
[2] Hosp Civils Lyon, Lyon, France
来源：
HEPATOLOGY | 2004年 / 40卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：398A / 398A
页数：1
相关论文
共 50 条
  • [31] IMPACT OF GENETIC CONCENTRATIVE NUCLEOSIDE TRANSPORTER VARIANTS ON PEG-INTERFERON/RIBAVIRIN THERAPY RESPONSE AND RIBAVIRIN SERUM LEVELS IN HEPATITIS C PATIENTS
    Rau, M.
    Weisskopf, M.
    Stickel, F.
    Schmitt, J.
    Russmann, S.
    Dill, M. T.
    Dufour, J. -F.
    Moradpou, D.
    Negro, F.
    Semela, D.
    Muellhaupt, B.
    Geier, A.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S455 - S456
  • [32] Neutralizing antibodies to interferon alpha in chronic hepatitis C patients non-responding to pegylated interferon plus ribavirin retreated to PEG-interferon α2a and ribavirin (ANRS gammatri)
    Halfon, Philippe
    Perusat, Sophie
    Bourliere, Marc
    Bronowicki, Jean-Pierre
    Trimoulet, P.
    Benhamou, Yves
    Leroy, V.
    Marcellin, Patrick
    Foucher, J.
    Chene, Genevieve
    Couzigou, Patrice
    HEPATOLOGY, 2007, 46 (04) : 669A - 669A
  • [33] Response of Black African patients with hepatitis C virus genotype 4 to treatment with peg-interferon and ribavirin
    Nkuize, M.
    Mulkay, J. -P.
    Adler, M.
    Lasser, L.
    Michielsen, P.
    de Galocsy, C.
    Assene, C.
    Delwaide, J.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2013, 76 (03) : 291 - 299
  • [34] Salivary glands impairment in patients with chronic hepatitis C undergoing PEG-Interferon/ribavirin treatment.
    Aghemo, AM
    Rumi, MG
    Cuccarini, V
    Paglia, M
    Ottaviani, F
    Del Ninno, E
    Colombo, M
    HEPATOLOGY, 2003, 38 (04) : 625A - 625A
  • [35] Retreatment of chronic hepatitis C patients with interferon alfa, ribavirin and amantadin
    Vucelic, B
    Hrstic, I
    Ostojic, R
    Rustemovic, N
    Opacic, M
    Falisevac, V
    Cavka, S
    Brkic, T
    Pulanic, R
    Krznaric, Z
    Premuzic, M
    Scukanec, M
    Grahovac, B
    Restek, N
    JOURNAL OF HEPATOLOGY, 2002, 36 : 236 - 236
  • [36] Treatment of Recurrent Hepatitis C after Liver Transplantation with PEG-Interferon and Ribavirin.
    Antonino, Anca-Teodora
    Fontana, Massimiliano
    Gioastra, Emiliano
    Moradpour, Darius
    Pascual, Manuel
    LIVER TRANSPLANTATION, 2011, 17 (06) : S149 - S149
  • [37] MULTICENTRE TRIAL OF PEG-INTERFERON α2A & RIBAVIRIN IN PEDIATRIC CHRONIC HEPATITIS C
    Sokal, Etienne M.
    Bourgois, Annick
    Stephenne, Xavier
    Porta, Gilda
    Silveira, Themis R.
    Gordovska, Dace
    Fischler, Bjorn
    Kelly, Deirdre A.
    HEPATOLOGY, 2009, 50 (04) : 418A - 419A
  • [38] Severe thrombocytopenia induced by pegylated (PEG)-interferon (IFN) plus ribavirin in hepatitis C patients
    Rodriguez, J. N.
    Rodriguez, G.
    Martin, E.
    Moreno, M. V.
    Palma, A.
    Dieguez, J. C.
    Quesada, J. A.
    Amian, A.
    Fernandez-Jurado, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 421 - 421
  • [39] Influence of serum ribavirin concentration and hemoglobin level on rapid virological reponse to telaprevir or to boceprevir Peg-Interferon ribavirin retreatment in HCV genotype 1 patients with severe liver fibrosis and a previous failure to Peg-Interferon and ribavirin treatment
    Alric, Laurent
    Bonnet, Delphine
    Palacin, Anais
    Thebault, Sophie
    Fooladi, Atoussa
    Sigur, Nicolas
    Nicot, Florence
    Abravanel, Florence
    Izopet, Jacques
    HEPATOLOGY, 2012, 56 : 1008A - 1008A
  • [40] Interferon alpha plus ribavirin tor chronic hepatitis C genotype 1b non-responder patients to interferon alone.
    Iacono, OL
    Castro, A
    Diago, M
    Cors, R
    Borque, MJ
    Buey, LG
    Monzon, CG
    Pedreira, J
    Otero, RM
    HEPATOLOGY, 1999, 30 (04) : 266A - 266A
12345